It is mandatory for the corresponding author to register with JFCN electronic manuscript tracking system before submitting an article. All articles should be prepared according below mentioned instructions and submitted with the following files: Cover letter, manuscript, figures and tables including legends, supplementary files (if any).

The cover letter should be addressed to the Editor-in-Chief of the journal and specify the type of article, title of the manuscript, summarize why it should be published and its value addition to the scientific literature.

In addition, the authors must state that the work is original and has not been published and is not submitted for publication anywhere else.

JFCN accommodates a wide range of manuscript structures and considers manuscripts of any length with no restrictions for the number of words, figures, or the length of the supporting information. All manuscripts should be typed in single column, double-spaced, and include line numbers and page numbers in order to facilitate the review process.

Generally for original research articles, manuscript file should include the following sections, in the below mentioned order: Title, Authors, Affiliations, Abstract, Introduction, Material & Methods, Results & Discussion, Acknowledgements, References, Figure Legends, Table Legends and Supplementary files, if any. Figures and Tables must be submitted as separate files while submitting online through the editorial manager.

Authors may submit their manuscript files in Word (as .doc or .docx), LaTeX (as .pdf), or RTF format.

Units used in the manuscript must be in accordance with the International System of Units and standardized recommended nomenclature should be used as appropriate. Authors should refer to chemical compounds and biomolecules using systematic nomenclature, preferably using International Union of Pure and Applied Chemistry (IUPAC).

For the manuscripts dealing with the microbial strains and cultures, the public culture collection (ATCC, ECACC, NCTC, NCIMB, MTCC, etc) deposition number should be provided. The PubChem compound identifier (CID) number from the NCBI PubChem Compound database should be provided, if chemical compounds are used for the research. The list of the chemical compounds (with PubChem CID) and the microbial strains (deposition number) should be positioned below the keywords section.

Standard abbreviations should be kept to a minimum and defined upon first use in the text whereas non-standard abbreviations should be avoided unless they appear at least four times in the text. Authors must consider listing the list of non-standard abbreviations at the end, immediately before the acknowledgments section of their manuscript. Equations should be inserted in editable format from the equation editor (MathType is highly recommended).

Manuscript file should contain the full article title and a short running title. The full title (maximum of 25 words) should be specific, concise and be a statement of the main finding or conclusion presented in the manuscript that can help the reader to decide whether they should read the text or not. Abbreviations should be avoided within the title. The running title should be a maximum of 6 words in length and should state the theme of the paper.

All author’s full names should be listed together with their respective affiliations which include the associated lab and/or department, university, or organization, city (pin or zip or post codes), state, country along with the phone numbers and email ids.

The abstract should:

• Render the concept and significance of the work
• Describe the main / primary objective of the study
• Briefly outline how the study was done
• Notify the important results / findings
• Should not exceed 250 words in length.

Authors should summarize the contents of the article in a pictorial form that clearly represent the work described in the article. Graphical abstracts (Illustration/Figure) should be submitted as a separate file in the online submission system.

Five to ten keywords (includes terms for indexing) representing the main content of the article

The introduction should illustrate the research objective addressing the problem and help the readers to understand the purpose and significance of the study. This section should include a brief review of the literature search to justify the importance of the study. Also, the section should end with a brief statement of what is being reported in the article.

The methods section should include the design of the study, methods and protocols, materials used (type of participants, if any), analytical procedures used and other information to allow other interested researchers to be able to reproduce your study.

For studies involving human or animal subjects, a statement detailing IACUC (Institutional Animal Care and Use Committee) /IRB (Institutional Review Board) and/or related ethical approval and consent should be included in the methods section. For further details of the journal editorial policies and ethical guidelines please refer to JFCN Editorial Policies.

The results and discussion may be combined into a single section or presented separately. Results section should include the interpretations and/or extrapolations of the readings/results of the analytical procedures with statistical approach, where appropriate. Discussion should help understand the problem and how the outcome of this study advances the current system.

Together, this section should describe the results of the experiments and interpretation with the previous related studies discussing the hypothesis presented as the basis of the study and provides a succinct explanation of the implications of the findings.

Cite references in the text by name and year in parentheses. For e.g.,

Subject area covers many disciplines (Victor, 1981).

This assumption of theory was approved by John and Daniel (1996).

This technique was effectively proved and has been widely reported (Peter, 1991; Goodmann et al., 1995; Black and Smith, 2008; Mandal et al., 2012).

This section should clearly summarize the main conclusions of the research giving clear explanation of their importance and emphasizing on potential future directions.

Authors should provide a list of abbreviations used in the text, and they should be defined in the text at first use.

JFCN follows the recommendations by the International Committee of Medical Journal Editors stating that all financial, commercial or other relationships that might be perceived by the academic community as representing a potential conflict of interest must be disclosed. If no such relationship exists, authors will be asked to declare that the research was conducted in the absence of any interests mentioned. For more details, see  JFCN Editorial policies.

This is a section to acknowledge persons (specific colleagues, institutions, or agencies) who have made substantial contributions to the design, implementation, acquisition of the data, analysis and interpretation of results and / or who was involved in drafting or revising the manuscript, but who do not fulfill the criteria to be included as an author. A statement about the source (s) of funding including grant numbers should be included, if appropriate.

All citations in the text, figures or tables must be in the reference list and vice-versa. References must be listed at the end of the manuscript and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in square brackets. Journal abbreviations follow Index Medicus/MEDLINE. Only published or accepted manuscripts should be included in the reference list.  For accepted but unpublished works, use in press instead of page numbers. Any inclusion of verbatim text must be contained in quotation marks and clearly reference the original source.

Examples of the JFCN reference style

Journal Article

Jung MY, Kwon TY, Park JS. 2013. Headspace–solid phase microextraction–gas chromatography–tandem mass spectrometry (HS-SPME-GC-MS2) method for the determination of pyrazines in perilla seed oils: Impact of roasting on the pyrazines in perilla seed oils. J Agric Food Chem 61(36): 8514–8523. https://doi.org/10.1021/jf402487a

In press article

Jung DM, Yoon SH, Jung MY. 2012. Chemical Properties and Oxidative Stability of Perilla Oils Obtained From Roasted Perilla Seeds As Affected by Extraction Methods. J Food Sci (In Press).

Article within conference proceedings

Jung MY. 2007. Nutritional and chemical properties of soybean oil as an alternative of trans fat (S12-3). In proceedings of International Symposium and Annual Meeting, The Korean Society of Food Science and Nutrition, Korea.

Complete book

Min DB, Smouse TH. 1989.  Flavor Chemistry of Lipid Foods. The American Oil Chemists Society Champaign, Illinois.

Article or Book chapter within a book

Jung MY, Min DB. 2004.  Novel hydrogenation for low trans fatty acids in vegetable oils.  In: Casimir CA, Oi-Ming OL (eds) Healthful Lipids. The American Oil Chemists Society Champaign, Illinois, pp 65-77.

Thesis

Philip P. 2014. Optimization of process parameters for the maximum production of Glutamic acid from fermentation broth containing molases. Ph. D Thesis, Columbia University, USA.

Patent

Susumu A and Rikichi M. 1965. Method for separation of Glutamic acid. US Patent 3,205,261.

Link / URL

The Japanese Society of Food Science and Technology. [http://www.jsfst.or.jp/e-page/index.html]

Clinical trial registration record

Mendelow, AD. Surgical Trial in Lobar Intracerebral Haemorrhage. Current Controlled Trials, 2006. https://doi.org/10.1186/ISRCTN22153967

Report of International Science Meets / Initiatives

World Health Organization Global initiative for the elimination of avoidable blindness. An informal consultation. WHO/PBL/97. 61. Geneva: WHO, 1997.

Figures and Tables files (including legends) must be submitted as separate files, not embedded in manuscript text. Legends should be included in the manuscript file and should be placed at the end of the manuscript. Legends are required to have a short title of 18 words or less and should describe the message of the figure or table. Legends should be preceded by the appropriate label, for example “Figure 1” or “Table 1”. Figure panels are referred to by bold capital letters in brackets: (A), (B), (C), (D), etc.

Tables: Tables should be created in Word, Excel or LaTeX and have a concise title. They must be primarily cell-based and editable. Graphics or colored fonts are not acceptable, instead bold or italic can be used to emphasize. Tables should be self-explanatory and include units in the column/row headings. For tables with analytical data, the reliability of the data in terms of number of replications with standard error should be given.

Figures: Figures should be of high-resolution files submitted in TIFF (or JPEG) or EPS (or PDF). Photos (both B/W and color) should be at least 300 dpi and line drawings 600 dpi. For certain scenarios such as need to print high-quality graphics, authors may be requested to submit higher resolution graphics.

Mark Image

Authors are recommended to submit a “mark image” that can be used to represent their article online in the journal homepage, table of contents, etc. Mark images should be single, high resolution, eye-catching image and ideally a cropped / full portion of image taken from the figures or raw images submitted as supporting information of the article. If no striking image is submitted, a figure from the paper will be designed as the mark image. Please do not submit any figures or photos that have been previously copyrighted unless you have explicit written permission from the copyright holder to publish.

For original full-length research articles and review articles, a synopsis are required which reflect in the content to represent their article online in the journal homepage, table of contents, etc. The content should specify the significance and emphasize the highlights of the research findings relative to the prior published studies or reports.

The data which is not of primary importance or cannot be included in the article because of its large size (array data, excel files, large size raw images etc.) or the current format (such as movies, raw data traces, power point presentations, etc.) can be uploaded as supplementary material during the submission procedure. The Supplementary Material can be uploaded as Figures (.FIG) and 3D imaging data (NIfTI), Data Sheet (word, excel, csv, fasta, pdf or zip files), Presentation (power point, pdf or zip files), Audio (mp3, wav or wma) or Movie (avi, divx, flv, mov, mp4, mpeg, mpg or wmv).

Articles that provide systematic, critical and constructive analyses of previously published material in a specific field, help in identifying research gaps and summarize the current understanding in the specific research field would be considered as review articles. The manuscript structure remains the same as mentioned for original full length research articles except that there would be a “review” / “body” instead of “results and discussion” section. The materials and methods section should contains for example the information about: selection criteria of studies, source of data/databases, search strategies, number of studies screened and included, statistical methods, softwares used, etc. The main content of the review article should focus on analyses of previously published methodological approaches, models tested, studies/theories that agree or disagree with each other etc. The text must be organized in chronological order and if applicable write each ideas/topics from different geographical location in separate paragraphs. It is important that the authors organize the different pieces on information logically justifying the objective of the review. The conclusions should answer the research questions mentioned in the introduction and gives a message that integrates the points discussed in the review which recommend new research areas.

In order for clinical trial results to be considered for publication in our journal (which adhere to ICMJE standards), all clinical trials that start recruiting patients or volunteers must be registered with a public registry before the enrolment of the first subject. This ensures that everyone can find key information about every clinical trial whose principal aim is to shape medical decision-making.

The ICMJE accepts registration of clinical trials in the following registries:

• www.anzctr.org.au 
• www.clinicaltrials.gov 
• www.ISRCTN.org 
• www.umin.ac.jp/ctr/index/htm 
• www.trialregister.nl 
• https://eudract.ema.europa.eu/ (new registrations after June 20, 2011)  

In addition to the above registries, starting in June 2007 the ICMJE will also accept registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (see http://www.who.int/ictrp/network/primary/en/index.html). 

Emerging technologies with implementation of new techniques in the processing, production, packing and engineering of food and food products has found ways for the potential to the food industry for enhancing product quality, quantity and extend shelf life of fresh and processed foods. Often these techniques do not have substantial peer-reviewed scientific data related to its basics for making a positive review and scientific conclusions. In order to make aware of such novel techniques with potential applications to the scientific community, it is appropriate for publication of articles with acceptable peer review.

The advised format for publication includes abstract, introduction, description of the technique, discussion, and references. The technique should be advanced and provide a remarkable advantage in the basic and applied food research. Commercial bias must be avoided and should fully disclose all competing interests or supports. Authors are encouraged to include videos (legends should describe the video; preferably not more than 10 MB in .MPEG video-audio format), images, figures if required. The details of the manufacturer name and their contact should not be included in the video, instead be cited in the text.

JFCN reserves the right to reject the manuscripts publication that do not meet the technical or ethical standards (COPE) according to the editorial policies and retract publications if any breach and/or misconduct of ethical standards, dispute of interests comes to light during post-publication peer review process.

Authors are sole responsible for any scientific misconduct including plagiarism in their research article; publisher is not responsible for any scientific misconduct happened in any published research article. As a publisher we will follow strictly scientific guidelines and EIC’s advice to retract or erratum of any article at any time if scientific misconduct or errors happened in any articles.

Chemical structures should be prepared using ChemDraw or other drawing programs and should select settings as close as possible according to the following given below:
However, JFCN believes that lack of funds should not be a barrier to open access publication and will consider discount or waiver to the APC on a case-by-case basis.

Drawing settings: chain angle – 120 degrees; bond spacing – 18% of width; bond length – 14.4 pt; bold width – 2.0 pt; line width – 0.6 pt; margin width – 1.6 pt; hash spacing – 2.5 pt.

Text settings: Atom labels and captions font – Arial or Helvetica; size – 10 pt.

Images must be submitted in the color mode RGB.

The databases for which we can provide direct links in the manuscript are: GenBank at the NCBI.((GenBank), EMBL Nucleotide Sequence Database (EMBL), Protein Data Bank (PDB), Protein Information Resource (PIR), Swiss-Prot Protein Database (Swiss-Prot) and DNA Data Bank of Japan (DDBJ).

The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript should be provided, in square brackets and include the corresponding database name (for example, [GenBank: JN872327]).

Animal Research

Studies involving animals must have been approved by the authors’ institutional animal care and use committee (IACUC). Appropriate approval documentation including institution, review board and permit numbers must be submitted as separate supplementary files, along with the manuscript. Manuscripts describing studies that use death as an endpoint will be subject to additional ethical considerations. Authors are encouraged to follow the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines and recommendations of the Weatherall report (2006) for all studies on non-human primates.

The methods section of manuscript reporting results of animal research must include required ethics statements that specify:

• The full name of the relevant ethics committee that approved the work, and the associated permit number(s) (If the ethical approval is not required, the reason for the same should be included);
• Relevant details for efforts taken to improve animal suffering.

For example:

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and in accordance with the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of ABC (Permit Number: 12-3456). All surgery was performed under Isofluorane anesthesia, and all efforts were made to minimize suffering.